Immunity to Melanoma Associated Antigens Detected by Both Leukocyte Adherence Inhibition and Antibody Dependent Cellular Cytotoxicity Assays

References

• Irie K, Irie R E, Morton D L. Humoral immune response to melanoma-associated membrane antigen and fetal brain antigen demonstrated by indirect membrane immunofluorescence. Cancer Immunol Immunother 1979; 6: 33–9
   Google Scholar
• Jones P C, Sze L L, Liu P Y, et al. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst 1981; 66: 249–54
   PubMed Web of Science ®Google Scholar
• Whitehead R H. Fluorescent antibody studies in malignant melanoma. Br J Cancer 1973; 28: 525–9
   Google Scholar
• Cornain S, Devries J E, Collard J, et al. Antibodies and antigen expression in human melanoma detected by immune adherence. Int J Cancer 1975; 16: 981–97
   Google Scholar
• Shiku H, Takahashi T, Oettgen H F, Old L J. Cell surface antigens of human malignant melanoma II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med 1976; 114: 873–81
   Google Scholar
• Shiku H, Takahashi T, Resnick L A, et al. Cell surface antigens of malignant melanoma III. Recognition of auto-antibodies with unusual characteristics. J Exp Med 1977; 145: 784–9
   Google Scholar
• Carey T, Takahashi T, Resnick L A, et al. Cell surface antigens of human malignant melanoma I. Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 1976; 73: 3278–82
   PubMed Web of Science ®Google Scholar
• Liao S K, Leong S PL, Sutherland C M, et al. Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cells. Cancer Res 1978; 38: 4395–400
   Google Scholar
• Gupta R K, Irie R K, Chee D O, et al. Demonstration of two distinct antigens in spent tissue culture medium of a human malignant melanoma cell line. J Natl Cancer Inst 1979; 63: 347–56
   Google Scholar
• Bodurtha A J, Chee D O, Laucius J F, et al. Clinical and immunological significance of human melanoma cytotoxic antibody. Cancer Res 1975; 35: 189–93
   PubMed Web of Science ®Google Scholar
• Hersey P, Honeyman M, Edwards A, et al. Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma sera. Int J Cancer 1976; 18: 564–73
   Google Scholar
• Hersey P, Edwards A E, Murray E, et al. Sequential studies of melanoma leukocyte-dependent antibody activity in melanoma patients. Eur J Cancer 1978; 14: 629–37
   Google Scholar
• Fossati G, Canevari S, Pierotti M A, et al. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients. J Natl Cancer Inst 1979; 62: 1381–5
   Google Scholar
• Hellström I, Hellström K E, Sjögren H O, Warner G A. Demonstration of cell mediated immunity to human neoplasms of various histological types. Int J Cancer 1971; 7: 1–16
   PubMed Web of Science ®Google Scholar
• Livingston P O, Shiku H, Bean M A, et al. Cell mediated cytotoxicity for cultured autologous melanoma cells. Int J Cancer 1979; 24: 34–44
   PubMed Web of Science ®Google Scholar
• Cannon G B, McCoy J L, Connor R J, et al. Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas. J Natl Cancer Inst 1979; 60: 969–78
   Google Scholar
• Jacubovich R, Dore J F. Tumour associated antigens in culture medium of malignant melanoma cell strains. Cancer Immunol Immunother 1979; 7: 59–64
   Google Scholar
• Roth J A, Chee D O, Gupta R K, Morton D L. Studies of lymphocyte stimulation to tumour-associated antigen II. Comparison of extracts from fresh human tumours with tissue culture cell lines. Cancer Immunol Immunother 1979; 7: 25–9
   Google Scholar
• Burger D R, Vanderbark A A, Finke P, et al. Assessment of reactivity to tumor extracts by leukocyte adherence inhibition and dermal testing. J Natl Cancer Inst 1977; 59: 317–23
   Google Scholar
• Halliday W J, Maluish A E, Little J H, Davis N C. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma. Int J Cancer 1975; 16: 645–58
   Google Scholar
• Marti J H, Thomson C MP. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition. Br J Cancer 1976; 34: 116–33
   PubMed Web of Science ®Google Scholar
• Winter M, Nelson D S, Milton G W. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma. Aust NZ J Med 1980; 10: 405–9
   Google Scholar
• Coakham H B, Kornblith P L, Quindlen E A, et al. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: In vitro study with the use of microcytotoxicity and immune adherence assays. J Natl Cancer Inst 1980; 64: 223–33
   Google Scholar
• Imai K, Ng A-K, Ferrone S. Characterisation of monoclonal antibodies to human melanoma-associated antigens. J Natl Cancer Inst 1981; 66: 489–96
   PubMed Web of Science ®Google Scholar
• Woodbury R G, Brown J P, Loop S M, et al. Analysis of normal and neoplastic human tissues for the tumour-associated antigen p97. Int J Cancer 1981; 27: 145–9
   PubMed Web of Science ®Google Scholar
• Urist M M, Boddie A W, Holmes E C, Morton D L. Capillary tube leukocyte adherence inhibition: An assay for cell mediated immunity in cancer patients. Int J Cancer 1976; 17: 338–41
   PubMedGoogle Scholar
• Gutterman J U, Mavligit G, McCredie K B, et al. Antigen solubilised from human leukaemia:lymphocyte stimulation. Science 1972; 177: 177–8
   Google Scholar
• Coates A, Crawford M. Growth of human melanoma cell lines in nude mice: suppression by human T lymphocytes from the tumor donor. J Natl Cancer Inst 1977; 59: 1325–9
   Google Scholar
• Pope J H, Morrison L, Moss D J, et al. Human malignant melanoma cell lines. Pathology 1979; 11: 191–5
   PubMed Web of Science ®Google Scholar
• Soule H D, Vazquez A, Long A, et al. Human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409–13
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1978; 21: 77–89
   Google Scholar
• Plain M J, Whitehead R H, Jose D G. Use of the antibody dependent cellular cytotoxicity test to detect antibodies in breast cancer patients. J Natl Cancer Inst 1981; 66: 619–24
   Google Scholar
• Plain M J, Whitehead R H, Jose D G. The detection of antibodies in breast cancer patient sera to ten breast cancer cell lines using antibody dependent cellular cytotoxicity. Clin Immunol Immunopathol 1982; 23: 392–9
   Google Scholar
• Engel L W, Young N A. Human breast carcinoma cells in continuous culture: A review. Cancer Res 1978; 38: 4327–39
   PubMed Web of Science ®Google Scholar
• Breast Cancer Task Force. Cell Culture Bank, current inventory. EG & G. Mason Research Institute, Rockville, MD 1977
   Google Scholar
• Tomkins G A, MacGregor A, Pye D, Atkinson M. Rapid detection and isolation of mycoplasmas from cell cultures. Aust J Exp Biol Med Sci 1975; 53: 257–63
   Google Scholar
• Koppi T AA, Maluish A E, Halliday W J. The cellular mechanism of leukocyte adherence inhibition. J Immunol 1979; 123: 2255–60
   PubMed Web of Science ®Google Scholar
• Marti J H, Grosser N, Thomson D MP. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody. Int J Cancer 1976; 18: 48–57
   PubMedGoogle Scholar
• Yeh M-Y, Hellström I, Brown J P, et al. Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci USA 1979; 76: 2927–31
   PubMed Web of Science ®Google Scholar
• Shore S L, Melewicz F M, Gordon D S. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus infected target cells. I. Identification of the population of effector cells. J Immunol 1977; 118: 558–66
   PubMed Web of Science ®Google Scholar
• Berkelhammer J, Mastralengo M J, Bellet R E, et al. Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients. Eur J Cancer 1978; 15: 197–204
   Google Scholar
• Minden P, Sharpton T S, McClatchy J K. Shared antigen between human malignant melanoma cells and mycobacterium bovis (BCG). J Immunol 1976; 116: 1407–14
   PubMedGoogle Scholar